366 participants
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2023-01-04
- Completion:
- 2027-09-30
Conditions
- Advanced Solid Tumors
- Genital Neoplasm, Female
- Urogenital Neoplasms
- Lung Neoplasm
- Neoplasms by Site
- Papillomavirus Infection
- Epstein-Barr Virus Infections
- Carcinoma
- Neoplasms
- Vulvar Neoplasms
- Vulvar Diseases
- Abdominal Neoplasm
- NSCLC (Non-small Cell Lung Cancer)
- Colorectal Cancer
Interventions
- DRUG
- COMBINATION_PRODUCT
No Results Yet